SANDY COLEMAN: Open Payments
NPI 1447667183 · ELLIJAY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 114 payments from 13 companies in 2025. Trend: 2023 $867 · 2024 $1,490 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $481 |
| E.R. Squibb & Sons, L.L.C. | 20 | $324 |
| Arcutis Biotherapeutics, Inc. | 9 | $280 |
| Novartis Pharmaceuticals Corporation | 10 | $187 |
| ABBVIE INC. | 13 | $143 |
| Lilly USA, LLC | 5 | $117 |
| Organon LLC | 5 | $66 |
| Galderma Laboratories, L.P. | 3 | $61 |
| GENZYME CORPORATION | 1 | $50 |
| LEO Pharma Inc. | 1 | $31 |
Products named: TREMFYA, Sotyktu, Zoryve, SKYRIZI, COSENTYX, EBGLYSS, NEMLUVIO, DUPIXENT.
Industry payments across GA — which companies pay providers there.
